FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065156942> ?p ?o ?g. }

• W2065156942 abstract "Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, ILNovel anti-cancer PNC-27 peptide, derived from the p53 binding domain of MDM2, induces necrosis of human pancreatic MiaPaCa-2 cancer cells but not normal cells in vitro, in a dose dependent fashion. Recent studies support a membranolytic mechanism of action for the peptide, initiated by binding of peptide monomers to the cells’ plasma membrane that subsequently aggregate to form transmembrane pores. Gemzar, on the other hand, is an established, non-selective chemotherapeutic used to treat pancreatic cancer. As a nucleoside analog, Gemzar inhibits DNA replication, resulting in cell cycle arrest, and ultimately apoptosis. Speculation regarding whether the two drugs, with different mechanisms, could produce a combined killing effect if administered simultaneously is investigated. Cell proliferation assays (MTT), cell cytotoxicity assays (LDH) and confocal microscopy were used to study the susceptibility of the MiaPaCa-2 cells to the co-treatment of PNC-27 and Gemzar. To determine the working concentration of PNC-27 that would result in pore formation but would not be cytotoxic to the cells, a dose response assay with serial dilutions was conducted. Results revealed that while MiaPaCa-2 cells treated with PNC-27 in DMEM have an LD50 = 150 ug/mL, the working concentration that would enable minimal pore formation without cell death was determined to be ∼10 ug/mL. Through confocal microscopy, it was then determined that propidium iodide (PI) (668.4 Da), a marker for dead cells and that is impermeable for intact cells, would nevertheless be able to enter the cell cytoplasm via PNC-27 pores. The results found PI staining in the cytoplasm but complete absence of nuclear staining. This observation not only indicates the sustained viability of the cells treated with 10 ug/mL PNC-27, but also supports the hypothesis that PI entered the cells through the PNC-27 induced pores. To explore a combined cytotoxic effect of Gemzar and PNC-27, MTT assays were carried out with Gemzar concentrations between 0 uM-100 uM for either 24 or 48 hours, in presence or absence of PNC-27. Our results demonstrate that co-treatment of MiaPaCa-2 cells with PNC-27 and Gemzar leads to a greater cytotoxic effect than with either Gemzar or PNC-27 alone. Additionally, the 48hr treatment resulted in a greater cytotoxic effect than did the 24hr condition. Our results indicate that the increased permeability of the cancer cells to Gemzar via the PNC-27-induced pores may allow for a more rapid mechanism of entry for Gemzar. Due to the selectivity of PNC-27, more Gemzar is able to target the cancer cells which have compromised membrane integrity caused by PNC-27. Therefore, co-treatment with Gemzar may allow for a dose reduction of Gemzar due to increased accessibility of the chemotherapeutic to its site of action. By reducing the dose of Gemzar required to achieve a significant cytotoxic effect, the severity of the side-effects of the drug experienced by patients may also be reduced.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2765A. doi:1538-7445.AM2012-2765A" @default.
• W2065156942 created "2016-06-24" @default.
• W2065156942 creator A5015105525 @default.
• W2065156942 creator A5067137008 @default.
• W2065156942 creator A5070425009 @default.
• W2065156942 creator A5073173853 @default.
• W2065156942 creator A5073908411 @default.
• W2065156942 creator A5074053475 @default.
• W2065156942 date "2012-04-15" @default.
• W2065156942 modified "2023-09-25" @default.
• W2065156942 title "Abstract 2765A: Co-treatment of human pancreatic cancer MiaPaCa-2 Cells with PNC-27 and Gemzar" @default.
• W2065156942 doi "https://doi.org/10.1158/1538-7445.am2012-2765a" @default.
• W2065156942 hasPublicationYear "2012" @default.
• W2065156942 type Work @default.
• W2065156942 sameAs 2065156942 @default.
• W2065156942 citedByCount "0" @default.
• W2065156942 crossrefType "proceedings-article" @default.
• W2065156942 hasAuthorship W2065156942A5015105525 @default.
• W2065156942 hasAuthorship W2065156942A5067137008 @default.
• W2065156942 hasAuthorship W2065156942A5070425009 @default.
• W2065156942 hasAuthorship W2065156942A5073173853 @default.
• W2065156942 hasAuthorship W2065156942A5073908411 @default.
• W2065156942 hasAuthorship W2065156942A5074053475 @default.
• W2065156942 hasConcept C109316439 @default.
• W2065156942 hasConcept C121608353 @default.
• W2065156942 hasConcept C126322002 @default.
• W2065156942 hasConcept C153911025 @default.
• W2065156942 hasConcept C154317977 @default.
• W2065156942 hasConcept C185592680 @default.
• W2065156942 hasConcept C190283241 @default.
• W2065156942 hasConcept C202751555 @default.
• W2065156942 hasConcept C2775934118 @default.
• W2065156942 hasConcept C2780210213 @default.
• W2065156942 hasConcept C2780258809 @default.
• W2065156942 hasConcept C2780783641 @default.
• W2065156942 hasConcept C31573885 @default.
• W2065156942 hasConcept C502942594 @default.
• W2065156942 hasConcept C55493867 @default.
• W2065156942 hasConcept C71924100 @default.
• W2065156942 hasConcept C86803240 @default.
• W2065156942 hasConcept C96232424 @default.
• W2065156942 hasConcept C98274493 @default.
• W2065156942 hasConceptScore W2065156942C109316439 @default.
• W2065156942 hasConceptScore W2065156942C121608353 @default.
• W2065156942 hasConceptScore W2065156942C126322002 @default.
• W2065156942 hasConceptScore W2065156942C153911025 @default.
• W2065156942 hasConceptScore W2065156942C154317977 @default.
• W2065156942 hasConceptScore W2065156942C185592680 @default.
• W2065156942 hasConceptScore W2065156942C190283241 @default.
• W2065156942 hasConceptScore W2065156942C202751555 @default.
• W2065156942 hasConceptScore W2065156942C2775934118 @default.
• W2065156942 hasConceptScore W2065156942C2780210213 @default.
• W2065156942 hasConceptScore W2065156942C2780258809 @default.
• W2065156942 hasConceptScore W2065156942C2780783641 @default.
• W2065156942 hasConceptScore W2065156942C31573885 @default.
• W2065156942 hasConceptScore W2065156942C502942594 @default.
• W2065156942 hasConceptScore W2065156942C55493867 @default.
• W2065156942 hasConceptScore W2065156942C71924100 @default.
• W2065156942 hasConceptScore W2065156942C86803240 @default.
• W2065156942 hasConceptScore W2065156942C96232424 @default.
• W2065156942 hasConceptScore W2065156942C98274493 @default.
• W2065156942 hasLocation W20651569421 @default.
• W2065156942 hasOpenAccess W2065156942 @default.
• W2065156942 hasPrimaryLocation W20651569421 @default.
• W2065156942 hasRelatedWork W149977637 @default.
• W2065156942 hasRelatedWork W1588538733 @default.
• W2065156942 hasRelatedWork W1982602744 @default.
• W2065156942 hasRelatedWork W2000096119 @default.
• W2065156942 hasRelatedWork W2016544926 @default.
• W2065156942 hasRelatedWork W2021188836 @default.
• W2065156942 hasRelatedWork W2028374439 @default.
• W2065156942 hasRelatedWork W2042447986 @default.
• W2065156942 hasRelatedWork W2053861335 @default.
• W2065156942 hasRelatedWork W2060551445 @default.
• W2065156942 hasRelatedWork W2066413859 @default.
• W2065156942 hasRelatedWork W2067225196 @default.
• W2065156942 hasRelatedWork W2333695010 @default.
• W2065156942 hasRelatedWork W2369500915 @default.
• W2065156942 hasRelatedWork W2377934031 @default.
• W2065156942 hasRelatedWork W2387637841 @default.
• W2065156942 hasRelatedWork W2387774931 @default.
• W2065156942 hasRelatedWork W2607302603 @default.
• W2065156942 hasRelatedWork W3004092562 @default.
• W2065156942 hasRelatedWork W3145226699 @default.
• W2065156942 isParatext "false" @default.
• W2065156942 isRetracted "false" @default.
• W2065156942 magId "2065156942" @default.
• W2065156942 workType "article" @default.